chrisvoncsefalvay/vaers-outcomes huggingface dataset:
About 24 hours after receiving the shot, I began to break out in red hives, with lots of itching covering my full body. My right arm and shoulder were even tighter hives, hot to the touch. I placed Calamine lotion on the skin, and it subsided in about 45 mins. The next day I had hives still on the insides of my arms, and tops of my feet. By Wednesday all was gone. I had no other side effects except for a very sore right arm, even after following protocol directions to drink plenty of water and use it as much as possible.
Mother brought child into Health Department on 3/28/13 and reported that after receiving immunizations on 8/1/12 child had a high fever and a seizure later in the day.  Mother did not report reaction to Health Department at that time. Unknown if private provider reported the event.
tingling in hand and buttocks; itchiness; burning sensation in the hand and buttocks; Dizziness; Body aches; Joint pain that still did not go away; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (tingling in hand and buttocks), PRURITUS (itchiness), BURNING SENSATION (burning sensation in the hand and buttocks), DIZZINESS (Dizziness) and MYALGIA (Body aches) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 002A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History Information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 25-Mar-2021, the patient experienced PARAESTHESIA (tingling in hand and buttocks), PRURITUS (itchiness), BURNING SENSATION (burning sensation in the hand and buttocks), DIZZINESS (Dizziness), MYALGIA (Body aches) and ARTHRALGIA (Joint pain that still did not go away). The patient was treated with PREDNISONE for Adverse event, at a dose of 1 dosage form. At the time of the report, PARAESTHESIA (tingling in hand and buttocks), PRURITUS (itchiness), BURNING SENSATION (burning sensation in the hand and buttocks), DIZZINESS (Dizziness), MYALGIA (Body aches) and ARTHRALGIA (Joint pain that still did not go away) had not resolved.            No concomitant medication was reported by the reporter.  Reported additional treatment was Advil.   Most recent FOLLOW-UP information incorporated above includes: On 22-Jul-2021: Significant follow up received
NUMBNESS IN TOES IN THE RIGHT FOOT; This spontaneous report received from a patient concerned a 67 year old female. The patient's height, and weight were not reported. The patient's past medical history included hypercholesterolemia, and concurrent conditions included hypothyroidism, hypersensitivity to bees wax, no alcohol use, and non smoker, and other pre-existing medical conditions included no drug abuse or illicit drug usage. family history of gout. she consumes biological food for about 40 years. The patient experienced drug allergy when treated with loracarbef.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1808978, and expiry: UNKNOWN) dose was not reported, administered on 24-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 10-JUL-2021, the subject experienced numbness in toes in the right foot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient had not recovered from numbness in toes in the right foot. This report was non-serious.
It started about 24 hours after the injection. I got bone pain and muscle pain and fatigue. I felt like I was coming down with the flu. I had chills. I checked my temperature, I had a fever that was 101 F. which increased to 104 degrees. I had nausea, no vomiting and I was unable to go to work for two days. Took Tylenol 650mg for the fever. I called the doctor the next morning after the first 24hours and they told me to stay hydrated and take Tylenol, take clear fluid and rest. They said if it does not get better in the morning they wanted me to come in.
C/O deltoid muscle sore, swollen, inflamed - unable to abduct arm for 1 week. Also had spasms in left arm once it started to move normally.
New onset Atrial Fibulation noticed in April diagnosised in July. Other symptoms include high blood pressure, shortness of breath, fatigue, swelling in ankles.
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
A report has been received from a Health Professional via Sales Representative concerning a child, male subject, who had been receiving Nasal FLUMIST. FLUMIST started on an unknown date. The patient experienced tested positive for the flu twice. The outcome of the event of tested positive for the flu twice is unknown. The report was considered to be non-serious by the reporter.
Parents say 3 days after the injection the left arm injection site became red and swollen and is still red and swollen and tender to touch without any fever or other symptoms associated with it.
pt recvd vax; cried inconsolably x 3 hrs; no fever reported
I started feeling sharp pain in my knee; it still hurting and swollen; I could hardly walk/ limping; This is a spontaneous report from a contactable consumer (patient). A 68-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Batch/Lot Number: EL9266, Expiry date: not reported), via an unspecified route of administration in left arm on 10Feb2021 (at age of 68-years-old) as dose 2, single for covid-19 immunisation. Medical history included hypertension and diabetes mellitus. Concomitant medication(s) included lisinopril (LISINOPRIL) taken for an unspecified indication, start and stop date were not reported; amlodipine (AMLODIPINE) taken for an unspecified indication, start and stop date were not reported. The patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9262, Expiration Date: Not reported), via an unspecified route of administration on 20Jan2021 as dose 1, single for covid-19 immunisation. On 11Feb2021, the patient started feeling sharp pain in my knee, it still hurting and swollen, the patient could hardly walk and was limping. When the patient came the next day 11th which was day before the reporting, before the patient went to work, started feeling sharp pain in the knee. Left knee was hurting and so as the patient got to the work then when the patient got off the work, she could hardly walk. The patient was limping to get to the car and so then she get off the car came home and elevated it and the patient called last night and it was around 8. The patient thought the recording said that all were busy but to leave a message so she left a message. So now up to the morning of reporting day and it still hurting and swollen so the patient was going to the urgent care but what the patient wanted to know was, was that one of the allergic reaction from the medicine. That's why the patient was calling. The patient also took bone health dietary supplement. Consumer stated she had lab work in last August. Consumer stated were they going to call her back or she need to call on the number which was given to her. Consumer was requested to dial the number that was provided. The outcome of the events I started feeling sharp pain in my knee; it still hurting and swollen was not recovered and the outcome of the events I could hardly walk and limping was unknown.  Follow-up attempts completed. No further information expected.  No follow-up attempts are possible. No further information is expected.
The patient stated to Dr. that her arm has been hurting since the vaccination. The patient came to the ED with complaints of left arm pain on 10/11/2021 and 12/28/2021.
On afternoon 8/1/07 area tenderness/ erythema around site of Dtap immunization developed still enlarging on 8/2/07 so brought to office where I measured it at 4pm at 6" x 6 1/2" - warm to touch and very tender. No lymphadenopathy in groin. No other signs of injection - Temp 99.6 (orally)
He got his vaccine, within 24 hours later he had hives, his lips and face swelled up, he had a low grade temp of 99.8 having chills and wanting to stay warm and lay in bed with multiple  blankets.  After his daughter noticed it about 2 hours later they went to the ER, and they gave him a steroid, Benadryl and a steroid and gave him IV Pepcid until the swelling went down and he felt better.   They gave him 6 days worth of Benadryl, and steroids which he did take for that.  After 6 days and after 24 hours he broke again in the same manner and they told him that it was okay as long as he was breathing well.  He then went to the UC and he bought OTC Benadryl which he continued.  Then exactly 30 days after he went to the ER on 4/24/21 he broke again with the lips swelling, hives, temperature was normal but feeling achy and the same symptoms he had from the beginning.  He went to his PCP and he has him now on steroids, Benadryl and the Pepcid when needed as well.  He takes the Benadryl as needed and then the symptoms subside and the reaction comes back.   If he does not do the Benadryl until later this evening then his lips will start tightening and then swell.
"Administered - 12:02 Adverse event started - 12:05 Patient had flushing/sweating, lightheadedness. Worked night shift per patient. BP 90/48 (57) -- > 101/65 (73), HR 71 -- >73, RR 16 -- > 16, O2 99% -- > 100%. Provided VSS, water, crackers. Patient stable, released from vaccination site."
he recieved vaccine in febr.  in august had dvt and bilat pe, died in september
no adverse event; All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border. Patients between 6m-5y of age. Were instead supposed to have received 0.25mL dosage of the dark blue cap and label with gray border presentation.; This spontaneous case was reported by an other health care professional and describes the occurrence of WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border. Patients between 6m-5y of age. Were instead supposed to have received 0.25mL dosage of the dark blue cap and label with gray border presentation.) and NO ADVERSE EVENT (no adverse event) in a child patient of an unknown gender who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 215K22A) for COVID-19 prophylaxis.     Patient did not received any other vaccines in the 4 weeks prior to COVID-19 vaccine.     In April 2023, the patient received first dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) 1 dosage form. In April 2023, the patient experienced WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border. Patients between 6m-5y of age. Were instead supposed to have received 0.25mL dosage of the dark blue cap and label with gray border presentation.). On an unknown date, the patient experienced NO ADVERSE EVENT (no adverse event). At the time of the report, WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border. Patients between 6m-5y of age. Were instead supposed to have received 0.25mL dosage of the dark blue cap and label with gray border presentation.) and NO ADVERSE EVENT (no adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (no adverse event) to be not related. No further causality assessment was provided for WRONG PRODUCT ADMINISTERED (All doses were given at a 0.2mL dosage from the presentation with the dark pink cap with yellow border. Patients between 6m-5y of age. Were instead supposed to have received 0.25mL dosage of the dark blue cap and label with gray border presentation.).    No concomitant medications were provided. Doses were administered from 24-Apr-2023 to 28-Apr-2023. Patients between 6m-5y of age were involved.  No reported symptoms. No treatment medication was provided. This case contains information for the 10th patient out of 12 child patients described by the reporter.   This case was linked to US-MODERNATX, INC.-MOD-2023-722123 (Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2023-722123:1st patient case (Master case)
Sore arm began 6 hours after injection and lasted 2 days. Fatigue and mild fever (99.5 F) began about 18 hours after injection and lasted 3 days.
mom states that pt began running t100.5 to 101 fever w/in 2 to 3 hrs p/inject was given; then fell asleep & awoke in about 1 1/2 hrs w/a fever of 105.2; took to ER was given APAP;
Patient received live virus varicella vaccine at 2 months of age. Parents counseled by provider.
Papillary Thyroid Tumor,had 2 nodules measuring 0.2mm and 0.7mm; had a thyroid surgery on 19MAR2021; This spontaneous case was reported by a consumer and describes the occurrence of THYROID NEOPLASM (Papillary Thyroid Tumor, had 2 nodules measuring 0.2mm and 0.7mm) and THYROIDECTOMY (had a thyroid surgery on 19MAR2021) in a 74-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 19-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced THYROIDECTOMY (had a thyroid surgery on 19MAR2021). On an unknown date, the patient experienced THYROID NEOPLASM (Papillary Thyroid Tumor,had 2 nodules measuring 0.2mm and 0.7mm). At the time of the report, THYROID NEOPLASM (Papillary Thyroid Tumor,had 2 nodules measuring 0.2mm and 0.7mm) and THYROIDECTOMY (had a thyroid surgery on 19MAR2021) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Patient called to inform that she had a partial thyroidectomy after her first dose of Moderna Covid-19 vaccination. Her first dose was on 19FEB2021, and second dose is 24MAR2021. Per patient her surgeon highly recommended to get the second dose of the vaccination. She was diagnosed with Papillary Thyroid Tumor, and had 2 nodules measuring 0.2mm and 0.7mm. Reports of doing well.  No concomitant was provided.  Treatment medication was not provided.  Company Comment: This is a spontaneous case concerning a 74-year-old female patient with no relevant medical history reported, who experienced non serious, unexpected events of Thyroid neoplasm and Thyroidectomy. The event Thyroid neoplasm occurred on an unknown date. Thyroidectomy occurred 1 month 1 day after the first dose of mRNA-1273 vaccine. Rechallenge is not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.   Most recent FOLLOW-UP information incorporated above includes: On 24-Mar-2021: Upon internal review on 16-Nov-2021, Company comment was added in the case.; Sender's Comments: This is a spontaneous case concerning a 74-year-old female patient with no relevant medical history reported, who experienced non serious, unexpected events of Thyroid neoplasm and Thyroidectomy. The event Thyroid neoplasm occurred on an unknown date. Thyroidectomy occurred 1 month 1 day after the first dose of mRNA-1273 vaccine. Rechallenge is not applicable. The benefit-risk relationship of mRNA-1273 vaccine is not affected by this report.
p/2 hrs pt woke from nap, rt arm was held stiff to body, refused to move arm, no s/s of redness, no swelling, no lumps, recvd APAP p/inject, vomited; pt slept then awoke crying, screaming, warm to touch, shaking legs;
Feels like an earache with pain scale of 3; Headache comes and goes; This spontaneous case was reported by a consumer and describes the occurrence of EAR PAIN (Feels like an earache with pain scale of 3) and HEADACHE (Headache comes and goes) in a 68-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004M20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included GABAPENTIN, AMLODIPINE, METFORMIN, ATORVASTATIN CALCIUM (LIPITOR), OMEPRAZOLE (PROTONIX [OMEPRAZOLE]), APOAEQUORIN (PREVAGEN [APOAEQUORIN]) and PARACETAMOL (TYLENOL ARTHRITIS) for an unknown indication.    On 09-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Feb-2021, the patient experienced EAR PAIN (Feels like an earache with pain scale of 3) and HEADACHE (Headache comes and goes). At the time of the report, EAR PAIN (Feels like an earache with pain scale of 3) and HEADACHE (Headache comes and goes) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Reporter did not allow further contact
Pt received covid shot. Co immediate nausea, blurred vision, dizziness and feeling cold and sweaty.  Skin warm and very diaphoretic.  BP 102/73, 101.  Pt given water to drink.  States all she has ate today is fruit.  Resting in chair.  Recheck 15 min later and BP 123/84, 64.  Drank 16 oz of water and states she feels much better.  No medical care required.  Advised to contact dr if symptoms return.
Patient received 2nd dose of Pfizer vaccine at 11:25 on 04/05/2021.  Reports that when he went to bed at 2:00am on 04/06/2021 he had no signs or symptoms concerning for allergic reaction.  Reports that when he woke up at 7:00am on 04/06/2021, his lower lip was swollen "to about twice the size of normal."  Reports swelling was greater on left side than on right side of lower lip.  Reports upper lip was not swollen.  Denies any other swelling of mouth/tongue/throat.  Denies any rash/flushing/hives/GI symptoms/lightheadedness/tachycardia/respiratory problems.  States he later took some benadryl and that swelling of lower lip resolved within two days.
I had cell phone trouble 11/3 and 4 and was not able to complete vsafe - CDC staff directed me  here.  11/2 from 9-16 hrs after jab- severe muscle aches, moderately feverish with moderate chills, moderate headache, anorexic with fatigue with difficulty trying to go to sleep. Mildly dehydrated. Jab site moderately hot, swollen and severely tender (couldn't raise arm above shoulder level without pain limiting motion).  11/3 anorexic, fatigued, slight headache; jab site moderately swollen , red and less tender (still hurts to try to raise arm above shoulder level). 11/4 mostly resolved but jab site still mildly tender and swollen but can move arm. 11/5 fully resolved except slight residual arm swelling at jab site.
11/1/2016 7:00 pm pt. noticed injection site is "inflamed", sore, warm, red and swelling. 11/2/16, 11:46 am. pt. called and informs of adverse reaction, pt. is advised to apply warm compress and TYLENOL as needed. 11/3/16 - Pt. is in office and examined symptoms improved. Pt. is in stable condition.
I've had tinnitus since taking my very first dose of Tamiflu on January 15, 2018.  Immediately after getting the 1st shot of the Pfizer COVID-19 vaccination, the volume of my tinnitus increased a lot and has maintained that increased volume.  It's AWFUL.  I'm afraid to take the second shot for fear that it will increase even more.
Moderna Covid-19 vaccine was initially stored in the refrigerator on 23-Feb-2022 and administered on 27-Mar-2022; dose administered from vial 33 days after stored in fridge; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (dose administered from vial 33 days after stored in fridge) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 23-Feb-2022 and administered on 27-Mar-2022) in a 33-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 27-Mar-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (dose administered from vial 33 days after stored in fridge). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 23-Feb-2022 and administered on 27-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (dose administered from vial 33 days after stored in fridge) and PRODUCT STORAGE ERROR (Moderna Covid-19 vaccine was initially stored in the refrigerator on 23-Feb-2022 and administered on 27-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not reported.  Vial did not undergo any temperature excursions.  It was reported that, analysis of the vials associated with your storage excursion was complete. The vaccine administered on 27-Mar-2022 from lot number 026L21B likely did not maintain the activity necessary to fully protect against the SARS-CoV-2 (COVID-19) virus at time of administration.  Treatment medications were not provided.   Most recent FOLLOW-UP information incorporated above includes: On 01-Apr-2022: Follow up received: Added suspect administration date, onset date of event expired vaccine use and updated narrative supplement.
Ear pain pulling sensation, down my neck  numbness jaw locking  on same side of injection
p/vax pt had pale face, pale lips;BP dec 88/50;pt given 02, monitored until vitals stable;
1 of 2 pts immunized from same DTAP vial who exp a rxn @ DTAP site; 5yo pt devel swollen & painful arm (erythematous & hot); MD visit-had red throat; no rx-recovered; also recvd Monovac test in opposite arm; had recvd 4 doses DTP w/no rxn
Headache, SkinRash, NauseaVomiting, fatigue. rash for doses for 48hrs Narrative: